Form SC 13G - Statement of acquisition of beneficial ownership by individuals
15 Febbraio 2024 - 12:10AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment
No. )*
Sagimet Biosciences Inc.
(Name
of Issuer)
Series A Common Stock, $0.0001 par value per share
(Title
of Class of Securities)
786700104
(CUSIP
Number)
December
31, 2023
(Date
of Event Which Requires Filing of This Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule
13d-1(b)
☐ Rule
13d-1(c)
☒ Rule
13d-1(d)
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover
page.
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18
of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall
be subject to all other provisions of the Act (however, see the Notes).
CUSIP
No. 786700104
|
13G |
Page
2 of 18 Pages |
1 |
|
NAMES
OF REPORTING PERSON(S)
New
Enterprise Associates 13, L.P.
|
|
|
2 |
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐ |
3 |
|
SEC
USE ONLY
|
|
|
4 |
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman
Islands
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH |
|
5 |
|
SOLE
VOTING POWER
0
Shares
|
|
6 |
|
SHARED
VOTING POWER
2,000,275 Shares
|
|
7 |
|
SOLE
DISPOSITIVE POWER
0
Shares
|
|
8 |
|
SHARED
DISPOSITIVE POWER
2,000,275 Shares
|
|
|
|
|
|
9 |
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,275 Shares
|
|
|
10 |
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐ |
11 |
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6%
|
|
|
12 |
|
TYPE
OF REPORTING PERSON
PN
|
|
|
CUSIP
No. 786700104
|
13G |
Page
3 of 18 Pages |
1 |
|
NAMES
OF REPORTING PERSON(S)
NEA
Partners 13, L.P.
|
|
|
2 |
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐ |
3 |
|
SEC
USE ONLY
|
|
|
4 |
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman
Islands
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH |
|
5 |
|
SOLE
VOTING POWER
0
Shares
|
|
6 |
|
SHARED
VOTING POWER
2,000,275 Shares
|
|
7 |
|
SOLE
DISPOSITIVE POWER
0
Shares
|
|
8 |
|
SHARED
DISPOSITIVE POWER
2,000,275 Shares
|
|
|
|
|
|
9 |
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,275 Shares
|
|
|
10 |
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐ |
11 |
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6%
|
|
|
12 |
|
TYPE
OF REPORTING PERSON
PN
|
|
|
CUSIP
No. 786700104
|
13G |
Page
4 of 18 Pages |
1 |
|
NAMES
OF REPORTING PERSON(S)
NEA
13 GP, LTD
|
|
|
2 |
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐ |
3 |
|
SEC
USE ONLY
|
|
|
4 |
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman
Islands
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH |
|
5 |
|
SOLE
VOTING POWER
0
Shares
|
|
6 |
|
SHARED
VOTING POWER
2,000,275 Shares
|
|
7 |
|
SOLE
DISPOSITIVE POWER
0
Shares
|
|
8 |
|
SHARED
DISPOSITIVE POWER
2,000,275 Shares
|
|
|
|
|
|
9 |
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,275 Shares
|
|
|
10 |
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐ |
11 |
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6%
|
|
|
12 |
|
TYPE
OF REPORTING PERSON
CO
|
|
|
CUSIP
No. 786700104
|
13G |
Page
5 of 18 Pages |
1 |
|
NAMES
OF REPORTING PERSON(S)
Forest
Baskett
|
|
|
2 |
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐ |
3 |
|
SEC
USE ONLY
|
|
|
4 |
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH |
|
5 |
|
SOLE
VOTING POWER
0 Shares
|
|
6 |
|
SHARED
VOTING POWER
2,000,275 Shares
|
|
7 |
|
SOLE
DISPOSITIVE POWER
0 Shares
|
|
8 |
|
SHARED
DISPOSITIVE POWER
2,000,275 Shares
|
|
|
|
|
|
9 |
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,275 Shares
|
|
|
10 |
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐ |
11 |
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6%
|
|
|
12 |
|
TYPE
OF REPORTING PERSON
IN
|
|
|
CUSIP
No. 786700104
|
13G |
Page
6 of 18 Pages |
1 |
|
NAMES
OF REPORTING PERSON(S)
Anthony A. Florence, Jr.
|
|
|
2 |
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐ |
3 |
|
SEC
USE ONLY
|
|
|
4 |
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH |
|
5 |
|
SOLE
VOTING POWER
0
Shares
|
|
6 |
|
SHARED
VOTING POWER
2,000,275 Shares
|
|
7 |
|
SOLE
DISPOSITIVE POWER
0
Shares
|
|
8 |
|
SHARED
DISPOSITIVE POWER
2,000,275 Shares
|
|
|
|
|
|
9 |
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,275 Shares
|
|
|
10 |
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐ |
11 |
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6%
|
|
|
12 |
|
TYPE
OF REPORTING PERSON
IN
|
|
|
CUSIP
No. 786700104
|
13G |
Page
7 of 18 Pages |
1 |
|
NAMES
OF REPORTING PERSON(S)
Patrick
J. Kerins
|
|
|
2 |
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐ |
3 |
|
SEC
USE ONLY
|
|
|
4 |
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH |
|
5 |
|
SOLE
VOTING POWER
0 Shares
|
|
6 |
|
SHARED
VOTING POWER
2,000,275 Shares
|
|
7 |
|
SOLE
DISPOSITIVE POWER
0 Shares
|
|
8 |
|
SHARED
DISPOSITIVE POWER
2,000,275 Shares
|
|
|
|
|
|
9 |
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,275 Shares
|
|
|
10 |
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐ |
11 |
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6%
|
|
|
12 |
|
TYPE
OF REPORTING PERSON
IN
|
|
|
CUSIP
No. 786700104
|
13G |
Page
8 of 18 Pages |
1 |
|
NAMES
OF REPORTING PERSON(S)
Mohamad H. Makhzoumi
|
|
|
2 |
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐ |
3 |
|
SEC
USE ONLY
|
|
|
4 |
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH |
|
5 |
|
SOLE
VOTING POWER
0 Shares
|
|
6 |
|
SHARED
VOTING POWER
2,000,275 Shares
|
|
7 |
|
SOLE
DISPOSITIVE POWER
0 Shares
|
|
8 |
|
SHARED
DISPOSITIVE POWER
2,000,275 Shares
|
|
|
|
|
|
9 |
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,275 Shares
|
|
|
10 |
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐ |
11 |
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6%
|
|
|
12 |
|
TYPE
OF REPORTING PERSON
IN
|
|
|
CUSIP
No. 786700104
|
13G |
Page
9 of 18 Pages |
1 |
|
NAMES
OF REPORTING PERSON(S)
Scott
D. Sandell
|
|
|
2 |
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐ |
3 |
|
SEC
USE ONLY
|
|
|
4 |
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH |
|
5 |
|
SOLE
VOTING POWER
0 Shares
|
|
6 |
|
SHARED
VOTING POWER
2,000,275 Shares
|
|
7 |
|
SOLE
DISPOSITIVE POWER
0 Shares
|
|
8 |
|
SHARED
DISPOSITIVE POWER
2,000,275 Shares
|
|
|
|
|
|
9 |
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,275 Shares
|
|
|
10 |
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐ |
11 |
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.6%
|
|
|
12 |
|
TYPE
OF REPORTING PERSON
IN
|
|
|
CUSIP
No. 786700104
|
13G |
Page
10 of 18 Pages |
Item 1(a). |
Name of Issuer: |
Sagimet Biosciences Inc.
Item 1(b). |
Address of
Issuer's Principal Executive Offices: |
155 Bovet Road, Suite 303., San Mateo, CA 94402
Item 2(a). |
Names of Persons
Filing: |
New Enterprise Associates
13, L.P. (“NEA 13”); NEA Partners 13, L.P. (“NEA Partners 13”), which is the sole general partner of NEA 13; NEA
13 GP, LTD (“NEA 13 GP”), which is the sole general partner of NEA Partners 13; Forest Baskett (“Baskett”), Patrick
J. Kerins (“Kerins”), and Scott D. Sandell (“Sandell”) (together, the “Directors”). Anthony A. Florence,
Jr. (“Florence”) and Mohamad H. Makhzoumi (“Makhzoumi”) are each members of the Executive Committee of NEA Management
Company, LLC (the “Executive Committee”).
The persons named in
this Item 2(a) are referred to individually herein as a “Reporting Person” and collectively as the “Reporting Persons.”
Item 2(b). |
Address of
Principal Business Office or, if none, Residence: |
The
address of the principal business office of NEA 13, NEA Partners 13, NEA 13 LTD, Kerins and Sandell is New Enterprise Associates,
1954 Greenspring Drive, Suite 600, Timonium, MD 21093. The address of the principal business office of Baskett and Makhzoumi is New
Enterprise Associates, 2855 Sand Hill Road, Menlo Park, California 94025. The address of the principal business office of
Florence is New Enterprise Associates, 104 Fifth Avenue, 19th Floor, New York, NY 10011.
Each of NEA 13 and
NEA Partners 13 is a Cayman Islands exempted limited partnership. NEA 13 GP is a Cayman Islands exempted company. Each of the Directors
is a United States citizen.
Each of Florence and Makhzoumi is a United States citizen.
Item 2(d). |
Title of Class
of Securities: |
Series A Common Stock, $0.0001 par value (“Common Stock”).
786700104
Item 3. |
If this statement
is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
Not
applicable.
CUSIP
No. 786700104
|
13G |
Page
11 of 18 Pages |
| (a) | Amount
Beneficially Owned: |
| (i) | NEA 13 is the record owner of 2,000,275 Common Stock as of February 5,
2024 (the “NEA 13 Shares”). As the sole general partner of NEA 13, NEA Partners 13 may be deemed to own beneficially the NEA
13 Shares. As the sole general partner of NEA Partners 13, NEA 13 GP likewise may be deemed to own beneficially the NEA 13 Shares. As
the individual directors of NEA 13 GP, each of the Directors also may be deemed to own beneficially the NEA 13 Shares. As an individual
member of the Executive Committee, which committee has been delegated certain approval rights with respect to dispositions of the NEA
13 Shares by the Directors, each of Florence and Makhzoumi may also be deemed to own beneficially the NEA 13 Shares. |
| (ii) | By virtue of their relationship as affiliated entities, whose controlling
entities have overlapping individual controlling persons, each of NEA 13, NEA Partners 13 and NEA 13 LTD may be deemed to share the power
to direct the disposition and vote of the NEA 13 Shares. |
| (b) | Percent
of Class: See Line 11 of cover sheets. The percentages set forth on the cover sheet for each
Reporting Person are calculated based on 30,375,402 Common Stock reported to be outstanding
immediately after the closing of an underwritten offering of 9,000,000 shares of Common
Stock, on the Issuer’s prospectus filed under Rule 424(b)(4), filed with the SEC on
January 29, 2024. |
| (c) | Number
of shares as to which such person has: |
| (i) | sole
power to vote or to direct the vote: See Line 5 of cover sheets. |
| (ii) | shared
power to vote or to direct the vote: See Line 6 of cover sheets. |
| (iii) | sole
power to dispose or to direct the disposition of: See Line 7 of cover sheets. |
| (iv) | shared
power to dispose or to direct the disposition of: See Line 8 of cover sheets. |
Each
Reporting Person disclaims beneficial ownership of such Securities except for the shares, if any, such Reporting Person holds of record.
Item 5. |
Ownership
of Five Percent or Less of a Class. |
Not
applicable.
Item 6. |
Ownership
of More than Five Percent on Behalf of Another Person. |
Not
applicable.
CUSIP
No. 786700104
|
13G |
Page
12 of 18 Pages |
Item 7. |
Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not
applicable.
Item 8. |
Identification
and Classification of Members of the Group. |
Not
applicable. The Reporting Persons expressly disclaim membership in a “group” as used in Rule 13d-5(b).
Item 9. |
Notice of
Dissolution of Group. |
Not
applicable.
Not
applicable. This Schedule 13G is not filed pursuant to Rule 13d-1(b) or Rule 13d–1(c).
Material
to be Filed as Exhibits.
Exhibit
1 – Agreement regarding filing of joint Schedule 13G.
Exhibit
2 – Power of Attorney regarding filings under the Securities Exchange Act of 1934, as amended.
CUSIP
No. 786700104
|
13G |
Page
13 of 18 Pages |
SIGNATURE
After
reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Date: February
14, 2024
NEW
ENTERPRISE ASSOCIATES 13, L.P.
| By: | NEA
PARTNERS 13, L.P.
General Partner |
| By: | NEA
13 GP, LTD
General Partner |
By: *
Scott D. Sandell
Director
NEA
PARTNERS 13, L.P.
| By: | NEA
13 GP, LTD
General Partner |
By:
*
Scott D. Sandell
Director
NEA
13 GP, LTD
By: *
Scott D. Sandell
Director
*
Forest
Baskett
*
Patrick
J. Kerins
*
Scott D. Sandell
CUSIP
No. 786700104
|
13G |
Page
14 of 18 Pages |
EXECUTIVE COMMITTEE:
*
Anthony A. Florence, Jr.
*
Mohamad H. Makhzoumi
*By:
/s/ Stephanie Brecher
Stephanie Brecher
As
attorney-in-fact
This Schedule 13G was executed by Stephanie Brecher on behalf of the individuals
listed above pursuant to a Power of Attorney, a copy of which is attached as Exhibit 2.
CUSIP
No. 786700104
|
13G |
Page
15 of 18 Pages |
Exhibit
1
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of
1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with
respect to the ownership by each of the undersigned of shares of stock of Sagimet Biosciences Inc.
EXECUTED this
14th day of February, 2024.
NEW
ENTERPRISE ASSOCIATES 13, L.P.
| By: | NEA
PARTNERS 13, L.P.
General Partner |
| By: | NEA
13 GP, LTD
General Partner |
By: *
Scott D. Sandell
Director
NEA
PARTNERS 13, L.P.
| By: | NEA
13 GP, LTD
General Partner |
By:
*
Scott D. Sandell
Director
NEA
13 GP, LTD
By: *
Scott D. Sandell
Director
*
Forest
Baskett
*
Patrick
J. Kerins
*
Scott D. Sandell
CUSIP
No. 786700104
|
13G |
Page
16 of 18 Pages |
EXECUTIVE COMMITTEE:
*
Anthony A. Florence, Jr.
*
Mohamad H. Makhzoumi
*By:
/s/ Stephanie Brecher
Stephanie Brecher
As
attorney-in-fact
This Agreement was executed by Stephanie Brecher on behalf of the individuals
listed above pursuant to a Power of Attorney, a copy of which is attached as Exhibit 2.
CUSIP
No. 786700104
|
13G |
Page
17 of 18 Pages |
Exhibit
2
POWER OF ATTORNEY
KNOW
ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Louis S. Citron, Timothy Schaller, Sasha Keough and Stephanie
Brecher, and each of them, with full power to act without the others, his or her true and lawful attorney-in-fact, with full power of
substitution, to sign any and all instruments, certificates and documents that may be necessary, desirable or appropriate to be executed
on behalf of himself as an individual or in his or her capacity as a direct or indirect general partner, director, officer or manager
of any partnership, corporation or limited liability company, pursuant to section 13 or 16 of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), and any and all regulations promulgated thereunder, and to file the same, with all exhibits
thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and with any other entity when
and if such is mandated by the Exchange Act or by the Financial Industry Regulatory Authority, granting unto said attorney-in-fact full
power and authority to do and perform each and every act and thing necessary, desirable or appropriate, fully to all intents and purposes
as he or she might or could do in person, thereby ratifying and confirming all that said attorney-in-fact, or his or her substitutes,
may lawfully do or cause to be done by virtue hereof.
IN
WITNESS WHEREOF, this Power of Attorney has been signed as of the 13th day of March, 2017.
/s/ M. James Barrett
M. James Barrett
/s/ Peter J. Barris
Peter J. Barris
/s/ Forest Baskett
Forest Baskett
/s/ Ali Behbahani
Ali Behbahani
/s/ Colin Bryant
Colin Bryant
/s/ Carmen Chang
Carmen Chang
/s/ Anthony A. Florence, Jr.
Anthony A.
Florence, Jr.
/s/ Carol G. Gallagher
Carol G. Gallagher
/s/ Dayna Grayson
Dayna Grayson
/s/ Patrick J. Kerins
Patrick J. Kerins
CUSIP
No. 786700104
|
13G |
Page
18 of 18 Pages |
/s/ P. Justin Klein
P. Justin Klein
/s/ Vanessa Larco
Vanessa Larco
/s/ Joshua Makower
Joshua Makower
/s/ Mohamad H. Makhzoumi
Mohamad H. Makhzoumi
/s/ Edward T. Mathers
Edward T. Mathers
/s/ David M. Mott
David M. Mott
/s/ Sara M. Nayeem
Sara M. Nayeem
/s/ Jason R. Nunn
Jason R. Nunn
/s/ Gregory Papadopoulos
Gregory Papadopoulos
/s/ Chetan Puttagunta
Chetan Puttagunta
/s/ Jon Sakoda
Jon Sakoda
/s/ Scott D. Sandell
Scott D. Sandell
/s/ A. Brooke Seawell
A. Brooke Seawell
/s/ Peter W. Sonsini
Peter W. Sonsini
/s/ Melissa Taunton
Melissa Taunton
/s/ Frank M. Torti
Frank M. Torti
/s/ Ravi Viswanathan
Ravi Viswanathan
/s/ Paul E. Walker
Paul E. Walker
/s/ Rick Yang
Rick Yang
Grafico Azioni Sagiment Biosciences (NASDAQ:SGMT)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Sagiment Biosciences (NASDAQ:SGMT)
Storico
Da Gen 2024 a Gen 2025